ChromaCon® and LEWA Sign Licensing Agreement

Agreement covers intellectual property relating to continuous processing of biopharmaceutical manufacturing products

ZURICH & DEVENS, Mass.--()--ChromaCon AG entered into a licensing agreement with LEWA Process Technologies. This agreement will enable the further development of each company’s current and future biopharmaceutical manufacturing technologies.

“Clients are now able to employ the GMP manufacturing technologies and global commercial reach of LEWA to further advance the use of ChromaCon’s CaptureSMB process,” said Michael Bavand, CEO at ChromaCon.

The companies have already started worldwide commercial collaboration activities to promote ChromaCon’s CaptureSMB chromatographic process technology, implemented in the LEWA EcoPrime chromatography equipment platform at the GMP scale.

The Capture SMB process principle allows faster processing, preserves drug molecule integrity, significantly decreases the use of expensive Protein A resins and uses less space on the manufacturing floor.

Gerard Gach, Chief Marketing Officer of LEWA Process Technologies (formerly Integrated Process Technologies) commented: “We are partnering with ChromaCon to advance the use of continuous chromatography for the benefit of our customers. EcoPrime LPLC is an innovation leader in precision processing and batch-to-batch reproducibility, and the agreement will enable both our companies to accelerate the development of advanced cost saving downstream processes for the biopharmaceutical manufacturing industry.”

Under the agreement, ChromaCon has granted LEWA license rights to intellectual property developed by ChromaCon for twin column bed chromatography. Additionally the parties agree to mutual collaboration in the process development, pilot and process scale.

LEWA Process Technologies provides advanced purification and fluid management systems and engineering services that are shaping a new age in Life Sciences manufacturing. We are aligned with LEWA GmbH, and Nikkiso, Corporation to leverage the global sales and service and fluid dynamic innovations of these multi-national leaders in fluid management and precision pumps. Headquartered in Devens, MA, USA, (formerly Integrated Process Technology, Inc.) LEWA Process Technologies is a unit of LEWA GmbH and its parent NIKKISO Co., Ltd.

ChromaCon AG is a private Life Science tool company located in Zürich, Switzerland, providing novel, best-in-class chromatographic process solutions to the biopharmaceutical industry. ChromaCon has developed and patented process principles, process control, equipment designs and operating software for cyclic and continuous chromatography, providing significant CAPEX and OPEX cost savings and enabling scalable chromatographic solutions for large scale purification applications. For more information about ChromaCon AG, please go to www.ChromaCon.ch.

Contacts

CommCreative
Samantha Schoenauer, 508-620-0791, ext. 18
samanthas@commcreative.com

Contacts

CommCreative
Samantha Schoenauer, 508-620-0791, ext. 18
samanthas@commcreative.com